Objective: To compare MR-imaging features in benign lipid-rich and lipid-poor adrenal adenomas.
Materials And Methods: With institutional review board approval, we compared 23 consecutive lipid-poor adenomas (chemical shift [CS] signal intensity [SI] index < 16.5%) imaged with MRI to 29 consecutive lipid-rich adenomas (CS-SI index ≥ 16.5%) imaged during the same time period. A blinded radiologist measured T2-weighted (T2W) SI ratio (adrenal adenoma/psoas muscle), dynamic enhancement wash-in (WI) and wash-out (WO) indices, and T2W texture features. Two blinded Radiologists (R1/R2) assessed T2W-SI (relative to renal cortex) and T2W heterogeneity (using 5-Point Likert scales). Comparisons were performed between groups using independent t tests and Chi-square with Holm-Bonferroni correction.
Results: There was no difference in age or gender between groups (p = 0.594, 0.051 respectively). Subjectively, all lipid-rich and lipid-poor adenomas were rated hypointense or isointense compared to renal cortex and T2W-SI did not differ between groups (p = 0.129, 0.124 for R1, R2). Agreement was substantial (Kappa = 0.67). There was no difference in T2W SI ratio (1.8 ± 0.9 [0.5-4.3] lipid rich versus 2.2 ± 1.0 [0.6-4.3] lipid poor, p = 0.139). Enhancement WI and WO did not differ comparing lipid-rich and lipid-poor adenomas (p = 0.759, 0.422 respectively). There was no difference comparing lipid-rich and lipid-poor adenomas T2W heterogeneity judged subjectively (p = 0.695, 0.139 for R1, R2; Kappa = 0.19) or by texture analysis (entropy, kurtosis, skewness; p = 0.134-0.191) with all adenomas except for one rated as mostly or completely homogeneous.
Conclusions: There is no difference in T2W signal intensity, enhancement pattern or T2W heterogeneity judged subjectively or by quantitative texture analysis comparing lipid-poor and lipid-rich adrenal adenomas.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00261-021-03161-1 | DOI Listing |
Eur J Pharm Sci
February 2025
Wellman Center for Photomedicine, Massachusetts General Hospital, 149 13th St, Charlestown, 02129, MA, USA. Electronic address:
Abdom Radiol (NY)
November 2024
Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Purpose: The extracellular matrix of adrenal metastases could be different from that of the adrenal adenomas, which may be characterized by the extracellular volume (ECV) fraction. This study aimed to assess the feasibility of ECV fraction derived from single-phase spectral CT for differentiating between adrenal metastases and adenomas.
Methods: This retrospective study included 163 patients with unilateral nodules, including lipid-poor adrenal adenoma (n = 52, group A), lipid-rich adrenal adenoma (n = 65, group B) and adrenal metastasis (n = 46, group C).
JCEM Case Rep
November 2024
Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Cortisol-producing adrenal adenomas consist of a mixture of lipid-rich clear and lipid-poor compact cells in varying proportions. Most adenomas are mainly composed of lipid-rich clear cells and typically exhibit low computed tomography (CT) attenuation values, high uptake on I-adosterol scintigraphy, and mild accumulation on F-fluorodeoxyglucose positron emission tomography/CT. However, adenomas predominantly composed of lipid-poor compact cells are rare, with limited evidence regarding their imaging characteristics.
View Article and Find Full Text PDFAbdom Radiol (NY)
September 2024
Dokuz Eylül University, Izmir, Turkey.
ACS Chem Biol
August 2024
Department of Cell Biology, Johns Hopkins University, Baltimore, Maryland 21205 United States.
Sterol regulatory element-binding protein (SREBP) transcription factors are central regulators of lipid homeostasis and are essential for lipid metabolic reprogramming that supports tumor growth in multiple cancers. SREBP pathway inhibitors have been identified, but bioavailable compounds are lacking. To address this need, we designed a novel approach for screening a collection of 4,474 FDA-approved drugs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!